Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001672659-26-000030 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 12, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
25,557
Total Value
$247,728.01
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 10, 2026 | Exercise/Conversion | 2,170 | $16.00 | $34,720.00 | 65,613 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 10, 2026 | Sale | 2,170 | $25.00 | $54,250.00 | 63,443 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 12, 2026 | Exercise/Conversion | 6,349 | $1.08 | $6,856.92 | 69,792 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 12, 2026 | Sale | 6,349 | $23.93 | $151,901.09 | 63,443 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jun 10, 2026 | Exercise/Conversion | 2,170 | $0.00 | $0.00 | 17,365 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jun 12, 2026 | Exercise/Conversion | 6,349 | $0.00 | $0.00 | 6,349 | Direct | โ | View Details |